Dr. Katia Khoury, MD
Claim this profileUniversity of Alabama at Birmingham
Studies Breast Cancer
Studies Breast cancer
7 reported clinical trials
19 drugs studied
Area of expertise
1Breast Cancer
Stage IV
HER2 positive
ER positive
2Breast Cancer
HER2 positive
ER negative
PR negative
Affiliated Hospitals
Clinical Trials Katia Khoury, MD is currently running
Enzalutamide + Mifepristone or Chemotherapy
for Breast Cancer
The researchers are doing this study to find out if the study drug, enzalutamide, alone or combined with the study drug, mifepristone, is effective in treating advanced or metastatic androgen receptor-positive (AR+) triple negative breast cancer (TNBC) or estrogen receptor-low breast cancer (ER-low BC), and whether these study treatments work as well as standard chemotherapy with carboplatin, paclitaxel, capecitabine, or eribulin.
Recruiting1 award Phase 218 criteria
Low Dose Capecitabine
for Breast Cancer
This is a phase II study aiming at evaluating capecitabine prospectively at a dose of 1000 mg once daily in patients with advanced breast cancer who are ≥60 years of age, or frail at any age, with a greater risk of complications and poorer outcomes with other treatments.
Recruiting1 award Phase 217 criteria
More about Katia Khoury, MD
Clinical Trial Related2 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Katia Khoury, MD has experience with
- Capecitabine
- Enzalutamide
- Mifepristone
- TPC
- U3-1402
- Anastrozole
Breakdown of trials Katia Khoury, MD has run
Breast Cancer
Locoregional Recurrence
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Katia Khoury, MD specialize in?
Katia Khoury, MD focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are HER2 positive.
Is Katia Khoury, MD currently recruiting for clinical trials?
Yes, Katia Khoury, MD is currently recruiting for 4 clinical trials in Birmingham Alabama. If you're interested in participating, you should apply.
Are there any treatments that Katia Khoury, MD has studied deeply?
Yes, Katia Khoury, MD has studied treatments such as Capecitabine, Enzalutamide, Mifepristone.
What is the best way to schedule an appointment with Katia Khoury, MD?
Apply for one of the trials that Katia Khoury, MD is conducting.
What is the office address of Katia Khoury, MD?
The office of Katia Khoury, MD is located at: University of Alabama at Birmingham, Birmingham, Alabama 35294 United States. This is the address for their practice at the University of Alabama at Birmingham.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.